Abstract

The present study aimed at evaluating the implications related to the implementation of a multi-dimensional approach for the study of alternative technologies (Ranibixumab, Dexamethasone and Aflibercept), for treating diabetic macular edema, in 4 Italian Regional settings: Lombardia, Liguria, Toscana and Veneto.4-8 November 201

    Similar works

    Full text

    thumbnail-image

    Available Versions